
Keywords: BBB; blood-brain barrier; EB; Evans Blue; GSK-3β; glycogen synthase kinase-3β; ICH; intracerebral hemorrhage; p-Akt; phospho-Akt; p-GSK-3β; phospho-glycogen synthase kinase-3β; p-β-catenin; phospho-β-catenin; TWS119; 4,6-disubstitutedpyrrolo-pyrim